CHI3L1 Gene

Introduction

Chi3L1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Pathway Diagram

flowchart TD
    CHI3L1["CHI3L1"]
    YKL_40["YKL-40"]
    CHI3L1 -->|"encodes"| YKL_40
    Neuroinflammation["Neuroinflammation"]
    CHI3L1 -->|"involved_in"| Neuroinflammation
    Hippocampal_Neurogenesis["Hippocampal Neurogenesis"]
    CHI3L1 -.->|"inhibits"| Hippocampal_Neurogenesis
    Astrocytes["Astrocytes"]
    CHI3L1 -->|"expressed in"| Astrocytes
    STAT3["STAT3"]
    CHI3L1 -->|"binds to"| STAT3
    Neural_Stem_Cell_Proliferation["Neural Stem Cell Proliferation"]
    CHI3L1 -.->|"inhibits"| Neural_Stem_Cell_Proliferation
    Neuronal_Differentiation["Neuronal Differentiation"]
    CHI3L1 -.->|"inhibits"| Neuronal_Differentiation
    CRTH2["CRTH2"]
    CHI3L1 -->|"binds"| CRTH2
    AQP4["AQP4"]
    AQP4 -->|"regulates"| CHI3L1
    AQP4_Autoantibodies["AQP4 Autoantibodies"]
    AQP4_Autoantibodies -->|"upregulates"| CHI3L1
    Astrocyte["Astrocyte"]
    Astrocyte -->|"product of"| CHI3L1
    hygromycin_B["hygromycin B"]
    hygromycin_B -.->|"inhibits"| CHI3L1
    style CHI3L1 fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style YKL_40 fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style Neuroinflammation fill:#e65100,stroke:#ff8a65,color:#ff8a65
    style Hippocampal_Neurogenesis fill:#e65100,stroke:#ff8a65,color:#ff8a65
    style Astrocytes fill:#263238,stroke:#90a4ae,color:#90a4ae
    style STAT3 fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style Neural_Stem_Cell_Proliferation fill:#e65100,stroke:#ff8a65,color:#ff8a65
    style Neuronal_Differentiation fill:#e65100,stroke:#ff8a65,color:#ff8a65
    style CRTH2 fill:#263238,stroke:#90a4ae,color:#90a4ae
    style AQP4 fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style AQP4_Autoantibodies fill:#1b5e20,stroke:#81c784,color:#81c784
    style Astrocyte fill:#263238,stroke:#90a4ae,color:#90a4ae
    style hygromycin_B fill:#1b5e20,stroke:#81c784,color:#81c784

Knowledge graph relationships for CHI3L1 (321 total edges in KG)

Overview

CHI3L1 (Chitinase 3-Like 1) is a secreted glycoprotein that serves as a biomarker for neuroinflammation in neurodegenerative diseases. Also known as YKL-40, it is produced by activated microglia, astrocytes, and macrophages in response to inflammatory stimuli. ^{1**Cell Signaling**: Interacts with IL-13Rα2 to activate MAPK and PI3K/Akt pathwaysCell Signaling}

Gene Information

Normal Function

CHI3L1 is a member of the glycosyl hydrolase family 18 but lacks enzymatic activity. It functions as:

• Extracellular matrix remodeling - binds to chitin, heparin, and collagen

• Cell proliferation and differentiation - modulates growth factor signaling

• Inflammatory response regulator - enhances cytokine production by immune cells

• Microglial activation marker - indicates neuroinflammatory states

Disease Associations

Alzheimer’s Disease

• Elevated CSF and plasma YKL-40 levels correlate with disease progression

• Associated with tau pathology and cognitive decline

• May predict conversion from MCI to AD

• Studied as a complementary biomarker to amyloid and tau

Parkinson’s Disease

• Increased YKL-40 in CSF of PD patients

• Correlates with disease severity and motor symptoms

• Associated with neuroinflammatory processes in substantia nigra

Multiple Sclerosis

• Strong marker for microglial activation

• Associated with lesion load and disease progression

• Different from classical inflammatory markers

Amyotrophic Lateral Sclerosis

• Elevated in CSF and serum

• Correlates with disease progression rate

• May reflect non-neuronal (glial) involvement

Expression Pattern

• Brain: Highly expressed in hippocampus, cortex, and basal ganglia

• Cell Types: Primarily microglia and astrocytes

• Induction: Pro-inflammatory cytokines (IL-1β, TNF-α, IFN-γ)

Therapeutic Implications

YKL-40 as a therapeutic target:

• Anti-inflammatory strategies may reduce YKL-40-mediated inflammation

• Monoclonal antibodies against YKL-40 in development

• Biomarker utility for patient stratification and treatment monitoring

Key Publications

1. YKL-40 in Alzheimer’s disease - Mathews et al., Neurology, 2013

2. YKL-40 as neuroinflammation marker in Parkinson’s disease - Wu et al., J Neuroinflammation, 2017

3. CSF YKL-40 in ALS patients - Sjögren et al., Neurology, 2016

4. YKL-40 in multiple sclerosis - Cantó et al., Mult Scler, 2012

5. YKL-40 and tau pathology - Querol-Vilaseca et al., JAD, 2017

Cross-Links

• Alzheimer’s Disease Biomarkers

• Parkinson’s Disease Biomarkers

• Neuroinflammation Pathway

• Microglia

• CSF Biomarkers

Background

The study of Chi3L1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• Alzheimer’s Disease

• Amyloid Hypothesis

• Tau Pathology

• Parkinson’s Disease

• Alpha-Synuclein

External Links

• NCBI Gene: CHI3L1

• UniProt: P36222

• GeneCards: CHI3L1

Expression Pattern

CHI3L1/YKL-40 shows cell-type and region-specific expression:

• Brain cells*: Primarily activated microglia and astrocytes

• Peripheral immune cells: Macrophages, neutrophils

• Brain regions*: Highest in hippocampus, basal ganglia, and white matter

• Disease states*: Expression increases dramatically in neuroinflammatory conditions

CSF and plasma YKL-40 levels provide information about ongoing neuroinflammatory processes in the central nervous system.

Molecular Mechanisms

Despite lacking enzymatic activity, CHI3L1 exerts multiple functions:

^{2**ECM Remodeling**: Binds to chitin, heparin, and various collagen typesECM Remodeling}: ECM Remodeling: Binds to chitin, heparin, and various collagen types ^{1**Cell Signaling**: Interacts with IL-13Rα2 to activate MAPK and PI3K/Akt pathwaysCell Signaling}: Cell Signaling: Interacts with IL-13Rα2 to activate MAPK and PI3K/Akt pathways ^{3**Cell Migration**: Promotes migration of macrophages and astrocytesCell Migration}: Cell Migration: Promotes migration of macrophages and astrocytes ^{4**Angiogenesis**: Induces endothelial cell proliferation and tube formationAngiogenesis}: Angiogenesis: Induces endothelial cell proliferation and tube formation ^{5**Inflammation**: Modulates cytokine production and immune cell activationInflammation}: Inflammation: Modulates cytokine production and immune cell activation

Cellular sources in the CNS:

• Microglia: Primary source in neurodegenerative diseases

• Astrocytes: Particularly in reactive astrocytes surrounding plaques

• Neurons: Limited expression, increases in stressed neurons

Therapeutic Implications

CHI3L1 as a biomarker and therapeutic target:

• Biomarker utility: YKL-40 levels correlate with disease progression

• Anti-YKL-40 antibodies: Being developed to neutralize YKL-40

• Small molecule inhibitors: Targeting IL-13Rα2 signaling

• Microglial modulation: Reducing CHI3L1-expressing microglia

Clinical applications:

• Prognostic biomarker in AD and PD

• Treatment response monitoring

• Disease progression tracking

Animal Models

• Chi3l1 knockout mice: Show altered inflammatory responses

• Transgenic overexpression: Develop enhanced neuroinflammation

• Mouse models of AD: YKL-40 correlates with plaque load

• PD models: Increased YKL-40 in substantia nigra

Research Directions

• Developing YKL-40-targeted therapeutics

• Understanding CHI3L1’s protective vs. pathogenic roles

• Biomarker validation in large clinical cohorts

• Multi-analyte biomarker panels including YKL-40